Inside Washington: Major Changes Ahead for FDA

November 15, 2002

Jill Wechsler

Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.

BioPharm International, BioPharm International-11-01-2002, Volume 15, Issue 11

by Jill Wechsler A new FDA commissioner will have to oversee agency consolidation and new initiatives to counter bioterrorism.

Related Content:

Outsourcing Outlook: Will CROs find opportunity in a Reinvigorated European R&D Sector?

Bioinformatics Databases ? Questions of Copyright

European Editor's Report ? An Industry Comes of Age